# A Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes Mellitus

> **NCT04564846** · PHASE2 · COMPLETED · sponsor: **Oramed, Ltd.** · enrollment: 49 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** ORMD-0801
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04564846
- **Lead sponsor:** Oramed, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-23
- **Primary completion:** 2022-06-07
- **Final completion:** 2022-06-07
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2024-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04564846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04564846, "A Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04564846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*